Angiodroid is a startup based in Italy, most recent round Series B, 3 tracked investors.
Angiodroid is a startup founded in 2026 based in Italy. Its most recent tracked round is Series B. Brouky records 3 investors associated with the company.
Angiodroid develops and markets an automatic CO2 injector for angiographic imaging, utilizing carbon dioxide as a biocompatible alternative to iodine contrast media. This technology enhances patient safety and diagnostic clarity, particularly for individuals with renal impairment or iodine allergies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.